{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:20:13Z","timestamp":1788862813378,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Gaucher disease (GD) is a genetic lysosomal disorder characterized by high bone marrow (BM) involvement and skeletal complications. The pathophysiology of these complications is not fully elucidated. Magnetic resonance imaging (MRI) is the gold standard to evaluate BM. This study aimed to apply machine-learning techniques in a cohort of Spanish GD patients by a structured bone marrow MRI reporting model at diagnosis and follow-up to predict the evolution of the bone disease. In total, 441 digitalized MRI studies from 131 patients (M: 69, F:62) were reevaluated by a blinded expert radiologist who applied a structured report template. The studies were classified into categories carried out at different stages as follows: A: baseline; B: between 1 and 4 y of follow-up; C: between 5 and 9 y; and D: after 10 years of follow-up. Demographics, genetics, biomarkers, clinical data, and cumulative years of therapy were included in the model. At the baseline study, the mean age was 37.3 years (1\u201380), and the median Spanish MRI score (S-MRI) was 8.40 (male patients: 9.10 vs. female patients: 7.71) (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). BM clearance was faster and deeper in women during follow-up. Genotypes that do not include the c.1226A&amp;gt;G variant have a higher degree of infiltration and complications (<jats:italic>p<\/jats:italic> = 0.017). A random forest machine-learning model identified that BM infiltration degree, age at the start of therapy, and femur infiltration were the most important factors to predict the risk and severity of the bone disease. In conclusion, a structured bone marrow MRI reporting in GD is useful to standardize the collected data and facilitate clinical management and academic collaboration. Artificial intelligence methods applied to these studies can help to predict bone disease complications.<\/jats:p>","DOI":"10.3389\/fmed.2023.1098472","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T06:30:59Z","timestamp":1683873059000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Advantages of digital technology in the assessment of bone marrow involvement in Gaucher's disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Esther","family":"Valero-Tena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Roca-Espiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Verd\u00fa-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Diaz-Manera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Andrade-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jbmr.3734","article-title":"Gaucher Disease in Bone: From Pathophysiology to Practice","volume":"34","author":"Hughes","year":"2019","journal-title":"J Bone Miner Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymgme.2020.12.291","article-title":"Gaucher disease: Basic and translational science needs for more complete therapy and management","volume":"132","author":"Grabowski","year":"2021","journal-title":"Mol Genet Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10354-010-0841-y","article-title":"An overview on bone manifestations in Gaucher disease","volume":"160","author":"Mikosch","year":"2010","journal-title":"Wien Med Wochenschr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch Intern Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00223-014-9923-y","article-title":"Gaucher disease and bone manifestations","volume":"95","author":"Marcucci","year":"2014","journal-title":"Calcif Tissue Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/ar.24461","article-title":"Is the cortical capillary renamed as the transcortical vessel in diaphyseal vascularity?","volume":"303","author":"Asghar","year":"2020","journal-title":"Anat Rec (Hoboken)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bcmd.2016.10.009","article-title":"Aberrant bone marrow vascularization patterns in untreated patients with Gaucher disease type 1","volume":"68","author":"Klimkowska","year":"2018","journal-title":"Blood Cells Mol Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.26044\/ecr2019\/C-2445","article-title":"Magnetic resonance imaging of bone marrow: a review","volume":"1","author":"Wang","year":"2012","journal-title":"Part I J Am Osteopath Coll Radiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11547-020-01239-2","article-title":"Bone marrow magnetic resonance imaging: physiologic and pathologic findings that radiologist should know","volume":"126","author":"Chiarilli","year":"2021","journal-title":"Radiol Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2214\/AJR.15.15294","article-title":"Standardization of MRI and scintigraphic scores for assessing the severity of bone marrow involvement in adult patients with type 1 gaucher disease","volume":"206","author":"Mariani","year":"2016","journal-title":"AJR Am J Roentgenol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1148\/radiol.2292020296","article-title":"Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging\u2014initial experience","volume":"229","author":"Maas","year":"2003","journal-title":"Radiology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejrad.2006.11.024","article-title":"S-MRI score: a simple method for assessing bone marrow involvement in Gaucher disease","volume":"62","author":"Roca","year":"2007","journal-title":"Eur J Radiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2214\/AJR.06.1410","article-title":"Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score","volume":"188","author":"Robertson","year":"2007","journal-title":"AJR Am J Roentgenol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3414\/ME16-01-0091","article-title":"Increasing the efficiency on producing radiology reports for breast cancer diagnosis by means of structured reports. A comparative study methods","volume":"56","author":"Segrelles","year":"2017","journal-title":"Inf Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1148\/radiol.2020201365","article-title":"The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the fleischner society","volume":"158","author":"Rubin","year":"2020","journal-title":"Chest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.21037\/qims-21-1191","article-title":"Structured bone marrow report as an assessment tool in patients with hematopoietic disorders","volume":"12","author":"Roca-Espiau","year":"2022","journal-title":"Quant Imaging Med Surg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","article-title":"reference standard for the description of osteoporosis","volume":"42","author":"Kanis","year":"2008","journal-title":"Bone."},{"key":"B18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13023-020-01520-7","article-title":"Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease","volume":"15","author":"Andrade-Campos","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"B19","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J Mach Learn Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2022.03.001","article-title":"The diagnosis and management of Gaucher disease in pediatric patients: where do we go from here?","volume":"136","author":"Weinreb","year":"2022","journal-title":"Mol Genet Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10545-010-9071-0","article-title":"Gaucher disease: a systematic review and meta-analysis of bone complications and their response to treatment","volume":"33","author":"Piran","year":"2010","journal-title":"J Inherit Metab Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bcmd.2017.06.003","article-title":"Skeletal involvement in type 1 Gaucher disease: not just bone mineral density","volume":"68","author":"Baldini","year":"2018","journal-title":"Blood Cells Mol Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"192761","DOI":"10.1155\/2015\/192761","article-title":"Pathogenesis of bone alterations in gaucher disease: the role of immune system","volume":"2015","author":"Mucci","year":"2015","journal-title":"J Immunol Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0126153","DOI":"10.1371\/journal.pone.0126153","article-title":"The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease","volume":"10","author":"Gervas-Arruga","year":"2015","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ymgme.2019.07.014","article-title":"Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease","volume":"128","author":"Afinogenova","year":"2019","journal-title":"Mol Genet Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bcmd.2010.10.010","article-title":"Potential biomarkers of osteonecrosis in Gaucher disease","volume":"46","author":"Pavlova","year":"2011","journal-title":"Blood Cells Mol Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3324\/haematol.2019.236083","article-title":"Accuracy of chitotriosidase activity and CCL18 concentration in assessing type I Gaucher disease severity. A systematic review with meta-analysis of individual participant data","volume":"106","author":"Raskovalova","year":"2021","journal-title":"Haematologica."},{"key":"B29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10545-008-0779-z","article-title":"vom Dahl S, Goldblatt J, et al. Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring","volume":"31","author":"Cox","year":"2008","journal-title":"J Inherit Metab Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13023-020-01656-6","article-title":"The International collaborative gaucher group GRAF (Gaucher Risk Assessment for Fracture) score: a composite risk score for assessing adult fracture risk in imiglucerase-treated Gaucher disease type 1 patients","volume":"16","author":"Deegan","year":"2021","journal-title":"Orphanet J Rare Dis."},{"key":"B31","unstructured":"Normal development and maturation of bone marrow. Assessment by magnetic resonance imaging420612\n            Londo\u00f1oMA\n            VallejoJM\n            ManzanoAC\n          Rev Colomb Radiol.262015"},{"key":"B32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2214\/ajr.167.2.8686603","article-title":"Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex","volume":"167","author":"Ishijima","year":"1996","journal-title":"AJR Am J Roentgenol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/00004728-200109000-00005","article-title":"Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers","volume":"25","author":"Maas","year":"2001","journal-title":"J Comput Assist Tomogr."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15858","article-title":"Fat fraction quantification of bone marrow in the lumbar spine using the LiverLab assessment tool in healthy adult volunteers and patients with Gaucher disease","author":"Gan","year":"2022","journal-title":"Intern Med J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"102591","DOI":"10.1016\/j.bcmd.2021.102591","article-title":"Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment","volume":"90","author":"Paskulin","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinimag.2020.02.009","article-title":"Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients","volume":"63","author":"Degnan","year":"2020","journal-title":"Clin Imaging."},{"key":"B37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bcmd.2016.11.004","article-title":"Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease. Possible impact of reporting experience","volume":"68","author":"Lai","year":"2018","journal-title":"Blood Cells Mol Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1053\/j.ro.2021.05.002","article-title":"Pediatric bone marrow: normal and abnormal MRI appearance","volume":"56","author":"Person","year":"2021","journal-title":"Semin Roentgenol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bjh.16915","article-title":"Machine learning and artificial intelligence in haematology","volume":"192","author":"Shouval","year":"2021","journal-title":"Br J Haematol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1016\/S2352-3026(20)30121-6","article-title":"Machine learning in haematological malignancies","volume":"7","author":"Radakovich","year":"2020","journal-title":"Lancet Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"747612","DOI":"10.3389\/fmed.2021.747612","article-title":"Opportunities and challenges for machine learning in rare diseases","volume":"8","author":"Decherchi","year":"2021","journal-title":"Front Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13023-020-01424-6","article-title":"The use of machine learning in rare diseases: a scoping review","volume":"15","author":"Schaefer","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1094","DOI":"10.1212\/WNL.0000000000009068","article-title":"Accuracy of a machine learning muscle MRI-based tool for the diagnosis of muscular dystrophies","volume":"94","author":"Verd\u00fa-D\u00edaz","year":"2020","journal-title":"Neurology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13023-017-0592-6","article-title":"new framework for evaluating the health impacts of treatment for Gaucher disease type 1","volume":"12","author":"Ganz","year":"2017","journal-title":"Orphanet J Rare Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1098472\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T06:31:06Z","timestamp":1683873066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1098472\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":44,"alternative-id":["10.3389\/fmed.2023.1098472"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1098472","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"article-number":"1098472"}}